{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:04:29Z","timestamp":1792195469387,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031851","name":"Masonic Foundation of Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000027","name":"Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031895","name":"Research Institute of St. Joe's Hamilton","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jare.2026.04.020","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:00:05Z","timestamp":1775494805000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["PCSK9 promotes prostate cancer via facilitating intratumoral cholesterol accumulation and enhancing immunosuppressive tumor microenvironment"],"prefix":"10.1016","author":[{"given":"Yan","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-9342","authenticated-orcid":false,"given":"Nabil G.","family":"Seidah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bonert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Werstuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jare.2026.04.020_b0005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.eururo.2013.11.002","article-title":"EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.jare.2026.04.020_b0010","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.seminoncol.2013.04.011","article-title":"The dilemma of a rising prostate-specific antigen level after local therapy: what are our options?","volume":"40","author":"Zaorsky","year":"2013","journal-title":"Semin Oncol"},{"issue":"10","key":"10.1016\/j.jare.2026.04.020_b0015","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2174\/138945012802429615","article-title":"Overcoming drug resistance and treating advanced prostate cancer","volume":"13","author":"Semenas","year":"2012","journal-title":"Curr Drug Targets"},{"issue":"15","key":"10.1016\/j.jare.2026.04.020_b0020","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1158\/0008-5472.CAN-12-4414","article-title":"A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer","volume":"73","author":"Mitsiades","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2026.04.020_b0025","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/srep01528","article-title":"Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer","volume":"3","author":"Ishizaki","year":"2013","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jare.2026.04.020_b0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2014.01.019","article-title":"Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness","volume":"19","author":"Yue","year":"2014","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.jare.2026.04.020_b0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.molcel.2017.02.015","article-title":"Cholesterol Modification of Smoothened is Required for Hedgehog Signaling","volume":"66","author":"Xiao","year":"2017","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.jare.2026.04.020_b0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","article-title":"Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities","volume":"2","author":"Huang","year":"2020","journal-title":"Nat Metab"},{"issue":"3","key":"10.1016\/j.jare.2026.04.020_b0045","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation","volume":"100","author":"Seidah","year":"2003","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.jare.2026.04.020_b0050","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/humu.9383","article-title":"Novel mutations of the PCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia","volume":"26","author":"Allard","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jare.2026.04.020_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.708039","article-title":"Association of serum anti-PCSK9 antibody levels with favorable postoperative prognosis in esophageal cancer","volume":"11","author":"Ito","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.jare.2026.04.020_b0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13058-022-01508-0","article-title":"Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer","volume":"24","author":"Sun","year":"2022","journal-title":"Breast Cancer Res: BCR"},{"issue":"15","key":"10.1016\/j.jare.2026.04.020_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153727","article-title":"Evaluating targeted therapies in ovarian cancer metabolism: novel role for PCSK9 and second generation mTOR inhibitors","volume":"13","author":"Jacome Sanz","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.jare.2026.04.020_b0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s13046-022-02477-0","article-title":"PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K\/AKT signaling in tumor cells and phenotypic polarization of macrophages","volume":"41","author":"Wang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.jare.2026.04.020_b0075","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00262-019-02367-z","article-title":"Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study","volume":"68","author":"Bonaventura","year":"2019","journal-title":"Cancer Immunol, Immunothe: CII"},{"issue":"1","key":"10.1016\/j.jare.2026.04.020_b0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40164-021-00218-1","article-title":"PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma","volume":"10","author":"Zhang","year":"2021","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jare.2026.04.020_b0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13046-022-02584-y","article-title":"PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity","volume":"42","author":"Gu","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jare.2026.04.020_b0090","doi-asserted-by":"crossref","first-page":"35354","DOI":"10.1038\/srep35354","article-title":"Targeting of CYP17A1 Lyase by VT-464 inhibits adrenal and intratumoral androgen biosynthesis and tumor growth of castration resistant prostate cancer","volume":"6","author":"Maity","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jare.2026.04.020_b0095","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1210\/en.2016-1926","article-title":"Inverse regulation of DHT synthesis enzymes 5alpha-reductase types 1 and 2 by the androgen receptor in prostate cancer","volume":"158","author":"Audet-Walsh","year":"2017","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.jare.2026.04.020_b0100","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ncpuro1237","article-title":"CYP17 inhibition as a hormonal strategy for prostate cancer","volume":"5","author":"Reid","year":"2008","journal-title":"Nat Clin Pract Urol"},{"issue":"12","key":"10.1016\/j.jare.2026.04.020_b0105","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1016\/j.cellsig.2013.08.041","article-title":"SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells","volume":"25","author":"Rybak","year":"2013","journal-title":"Cell Signal"},{"issue":"2","key":"10.1016\/j.jare.2026.04.020_b0110","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/er.2002-0032","article-title":"Androgen receptor in prostate cancer","volume":"25","author":"Heinlein","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jare.2026.04.020_b0115","article-title":"The TRAMP mouse as a model for prostate cancer","volume":"20","author":"Hurwitz","year":"2001","journal-title":"Curr Protoc Immunol"},{"issue":"21","key":"10.1016\/j.jare.2026.04.020_b0120","first-page":"4687","article-title":"Androgen-independent prostate cancer progression in the TRAMP model","volume":"57","author":"Gingrich","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2026.04.020_b0125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.cellbio.22.010305.104656","article-title":"Cholesterol sensing, trafficking, and esterification","volume":"22","author":"Chang","year":"2006","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.jare.2026.04.020_b0130","first-page":"110","article-title":"Staining of cholesterol with the fluorescent antibiotic \u201cfilipin\u201d","volume":"50","author":"Bornig","year":"1974","journal-title":"Acta Histochem"},{"issue":"12","key":"10.1016\/j.jare.2026.04.020_b0135","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2174\/1568026611313120002","article-title":"CYP17A1: a biochemistry, chemistry, and clinical review","volume":"13","author":"Porubek","year":"2013","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"10.1016\/j.jare.2026.04.020_b0140","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4149\/gpb_2017024","article-title":"The role of CYP17A1 in prostate cancer development: structure, function, mechanism of action, genetic variations and its inhibition","volume":"36","author":"Kmetova Sivonova","year":"2017","journal-title":"Gen Physiol Biophys"},{"issue":"13","key":"10.1016\/j.jare.2026.04.020_b0145","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1158\/1078-0432.CCR-06-0184","article-title":"Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers","volume":"12","author":"Xu","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"45","key":"10.1016\/j.jare.2026.04.020_b0150","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1038\/onc.2013.463","article-title":"Androgens regulate prostate cancer cell growth via an AMPK-PGC-1alpha-mediated metabolic switch","volume":"33","author":"Tennakoon","year":"2014","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.jare.2026.04.020_b0155","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.1158\/0008-5472.CAN-09-0775","article-title":"Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism","volume":"69","author":"Tamura","year":"2009","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.jare.2026.04.020_b0160","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/pros.24019","article-title":"Increased nuclear factor I\/B expression in prostate cancer correlates with AR expression","volume":"80","author":"Nanda","year":"2020","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.jare.2026.04.020_b0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","article-title":"Multiple defects in innate and adaptive immunologic function in NOD\/LtSz-scid mice","volume":"154","author":"Shultz","year":"1995","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.jare.2026.04.020_b0170","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"issue":"29","key":"10.1016\/j.jare.2026.04.020_b0175","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adm8660","article-title":"Targeting conserved TIM3(+)VISTA(+) tumor-associated macrophages overcomes resistance to cancer immunotherapy","volume":"10","author":"Vanmeerbeek","year":"2024","journal-title":"Sci Adv"},{"issue":"D1","key":"10.1016\/j.jare.2026.04.020_b0180","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gkae1142","article-title":"CZ CELLxGENE Discover: a single-cell data platform for scalable exploration, analysis and modeling of aggregated data","volume":"53","author":"Program","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.jare.2026.04.020_b0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/path.5751","article-title":"Single-cell analysis of mouse and human prostate reveals novel fibroblasts with specialized distribution and microenvironment interactions","volume":"255","author":"Joseph","year":"2021","journal-title":"J Pathol"},{"key":"10.1016\/j.jare.2026.04.020_b0190","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59465","article-title":"A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitors","volume":"9","author":"Crowley","year":"2020","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.jare.2026.04.020_b0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41467-021-27322-4","article-title":"Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states","volume":"13","author":"Song","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jare.2026.04.020_b0200","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","article-title":"Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer","volume":"3","author":"Dong","year":"2020","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.jare.2026.04.020_b0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","article-title":"Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression","volume":"23","author":"Chen","year":"2021","journal-title":"Nat Cell Biol"},{"issue":"11","key":"10.1016\/j.jare.2026.04.020_b0210","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","article-title":"Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment","volume":"39","author":"Kfoury","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jare.2026.04.020_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676181","article-title":"The Role of V-domain Ig suppressor of T cell activation (VISTA) in Cancer therapy: lessons learned and the road ahead","volume":"12","author":"Hosseinkhani","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jare.2026.04.020_b0220","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm.4308","article-title":"VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer","volume":"23","author":"Gao","year":"2017","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.jare.2026.04.020_b0225","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-25-0326","article-title":"Sig27 stratifies prostate cancer recurrence by assessing the immunosuppressive properties of tumors","volume":"32","author":"Neira","year":"2025","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.jare.2026.04.020_b0230","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/ni.2849","article-title":"Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells","volume":"15","author":"Mahmud","year":"2014","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.jare.2026.04.020_b0235","doi-asserted-by":"crossref","first-page":"e1416","DOI":"10.1002\/ctm2.1416","article-title":"Single-cell transcriptomics identify TNFRSF1B as a novel T-cell exhaustion marker for ovarian cancer","volume":"13","author":"Gao","year":"2023","journal-title":"Clin Transl Med"},{"issue":"24","key":"10.1016\/j.jare.2026.04.020_b0240","doi-asserted-by":"crossref","first-page":"9820","DOI":"10.1073\/pnas.0903849106","article-title":"A proprotein convertase subtilisin\/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates","volume":"106","author":"Chan","year":"2009","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.jare.2026.04.020_b0245","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1073\/pnas.92.8.3439","article-title":"Prostate cancer in a transgenic mouse","volume":"92","author":"Greenberg","year":"1995","journal-title":"PNAS"},{"issue":"18","key":"10.1016\/j.jare.2026.04.020_b0250","first-page":"4096","article-title":"Metastatic prostate cancer in a transgenic mouse","volume":"56","author":"Gingrich","year":"1996","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.jare.2026.04.020_b0255","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/en.2018-00220","article-title":"Comparing postnatal development of gonadal hormones and associated social behaviors in rats, mice, and humans","volume":"159","author":"Bell","year":"2018","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.jare.2026.04.020_b0260","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ccell.2023.04.016","article-title":"Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity","volume":"41","author":"Yan","year":"2023","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.jare.2026.04.020_b0265","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1677\/ERC-08-0079","article-title":"Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion","volume":"15","author":"Latini","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jare.2026.04.020_b0270","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/bs.vh.2016.10.002","article-title":"Emergent role of coronin-1a in neuronal signaling","volume":"104","author":"Martorella","year":"2017","journal-title":"Vitam Horm"},{"issue":"10","key":"10.1016\/j.jare.2026.04.020_b0275","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/s12276-024-01317-9","article-title":"Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2","volume":"56","author":"Jo","year":"2024","journal-title":"Exp Mol Med"},{"issue":"9","key":"10.1016\/j.jare.2026.04.020_b0280","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11910-016-0685-y","article-title":"Alemtuzumab for multiple sclerosis","volume":"16","author":"Willis","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4","key":"10.1016\/j.jare.2026.04.020_b0285","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00430-020-00677-z","article-title":"Tetraspanin CD53: an overlooked regulator of immune cell function","volume":"209","author":"Dunlock","year":"2020","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.jare.2026.04.020_b0290","article-title":"The function and mechanism of LAPTM5 in diseases","volume":"178","author":"Zhang","year":"2024","journal-title":"Biomed Pharmacother = Biomedecine & Pharmacotherapie"},{"issue":"1","key":"10.1016\/j.jare.2026.04.020_b0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00281-021-00842-3","article-title":"Thymus and autoimmunity","volume":"43","author":"Marx","year":"2021","journal-title":"Semin Immunopathol"},{"issue":"1","key":"10.1016\/j.jare.2026.04.020_b0300","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2007.04.043","article-title":"Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin","volume":"130","author":"Jayachandran","year":"2007","journal-title":"Cell"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226002997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226002997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:34:44Z","timestamp":1776195284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123226002997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":60,"alternative-id":["S2090123226002997"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2026.04.020","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCSK9 promotes prostate cancer via facilitating intratumoral cholesterol accumulation and enhancing immunosuppressive tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2026.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}